|
February 9, 2010
|
| 12:22 EDT |  | GSK |
|
| 10:37 EDT |  | GSK |
|
| 08:11 EDT |  | GSK |
|
|
February 8, 2010
|
| 09:20 EDT |  | GSK |
|
|
February 5, 2010
|
| 11:57 EDT |  | GSK |
|
| 07:41 EDT |  | GSK |
|
| 06:59 EDT |  | GSK |
|
|
February 4, 2010
|
| 10:33 EDT |  | GSK |
| theflyonthewall.com: | GlaxoSmithKline to form rare diseases drug development unit, DJ reports | | Marc Dunoyer will lead new operation, Dow Jones reports. The unit will seek in-licensing opportunities. :theflyonthewall.com |
|
| 09:26 EDT |  | GSK |
|
| 09:25 EDT |  | GSK |
|
| 07:11 EDT |  | GSK |
| theflyonthewall.com: | Pfizer to reduce R&D as it absorbs Wyeth, WSJ reports | | Pfizer (PFE) plans to cut its R&D spending by up to $3B by 2012, which was more than 25% of the combined R&D of Pfizer and newly acquired Wyeth in 2008, reports the Wall Street Journal. The move is based on efficiencies without hurting future product development. Reference Link :theflyonthewall.com |
|
|
February 1, 2010
|
| 06:29 EDT |  | GSK |
|
|
January 31, 2010
|
| 12:42 EDT |  | GSK |
| theflyonthewall.com: | TYKERB gets FDA approval for combination treatment in metastatic breast cancer |
Subscribe for More Information :theflyonthewall.com |
|
|
January 29, 2010
|
| 17:35 EDT |  | GSK |
|